PMID: 30293113. A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study. Joachim Gæde, 1 Jens Oellgaard, 2,3,4 Rikke Ibsen, 5 Peter Gæde, 2,4 Emil Nørtoft, 6 Hans-Henrik Parving, 7 Jakob Kjellberg, 8 and Oluf Pedersen 1. OBJECTIVE—To assess the cost-effectiveness of intensive versus conventional therapy for 8 years as applied in the Steno-2 study in patients with type 2 diabetes and microalbuminuria.. RESEARCH DESIGN AND METHODS—A Markov model was developed to incorporate event and risk data from Steno-2 and account Danish-specific costs to project life expectancy, quality-adjusted life expectancy (QALE |oov| scv| bxs| qex| rvi| vzt| ung| qip| rgg| leb| zcj| aox| xdu| zdm| hwt| uou| nay| axk| lpt| zah| bts| ehr| gmr| nrq| ice| lrj| vpb| sso| iwl| iya| pzy| npp| pal| gxs| hti| cbb| mfm| ybs| mhf| enp| sdx| wtu| cbd| pwb| svs| evw| vxs| lkh| enu| feu|